Asthma and Copd 2014
April 2 - 3, 2014
london , United Kingdom
The global market for Asthma and COPD drugs is set to reach $47bn in 2017. There is a growing demand for the next generation of inhaled combination products and novel therapeutics.
Asthma and COPD 2014 will enable delegates to gain valuable insights into the latest ground-breaking advances in the respiratory drug market. It will focus on the challenges and strategies to enhance patient outcomes, providing extensive knowledge from the key leading industry and academic experts.
Asthma and COPD 2014 will enable delegates to gain valuable insights into the latest ground-breaking advances in the respiratory drug market. It will focus on the challenges and strategies to enhance patient outcomes, providing extensive knowledge from the key leading industry and academic experts.
Related events
Asthma and Copd March 29 - 30, 2017
Asthma and Copd April 13 - 14, 2015
Asthma and Copd April 2 - 3, 2014
